Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Neehar, Parikh"'
Publikováno v:
Liver Cancer (2024)
Introduction: Given suboptimal performance of ultrasound-based surveillance for early hepatocellular carcinoma (HCC) detection in patients with cirrhosis, there is interest in alternative surveillance strategies, including blood-based biomarkers. We
Externí odkaz:
https://doaj.org/article/66266f17fd1a41868e65e7d614aed59f
Autor:
Neehar, Parikh
Publikováno v:
Gastroenterol Hepatol (N Y)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::25d31143d3f3aedb49cfe22d96c38f6f
https://europepmc.org/articles/PMC9972601/
https://europepmc.org/articles/PMC9972601/
Publikováno v:
Cancers; Volume 14; Issue 23; Pages: 5970
We have previously identified alterations in glycosylation on serum proteins from patients with HCC and developed plate-based assays using lectins to detect the change in glycosylation. However, heterophilic antibodies, which increase with non-malign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccd57306608470e32b5c61445ae118e4
https://pubmed.ncbi.nlm.nih.gov/36497452
https://pubmed.ncbi.nlm.nih.gov/36497452
Autor:
Daniel J. Herr, Chang Wang, Mishal Mendiratta-Lala, Martha Matuszak, Charles S. Mayo, Yue Cao, Neehar Parikh, Randy Ten Hanken, Dawn Owen, Teodor Stanescu, Michael Yan, Laura A. Dawson, Matthew Schipper, Theodore S. Lawrence, Kyle C. Cuneo
Publikováno v:
Cancer Research. 83:CT151-CT151
Introduction: Stereotactic body radiation therapy (SBRT) for the treatment of hepatocellular carcinoma (HCC) remains a challenge due to high rates of toxicity in patients with impaired liver function or tumors not amenable to thermal ablation. We per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6b873eeaf9ae9ee61b4995df705f162
https://doi.org/10.1158/1538-7445.am2023-ct151
https://doi.org/10.1158/1538-7445.am2023-ct151
Autor:
Neehar Parikh, Amit Singal
Publikováno v:
Hepatology (Baltimore, Md.). 76(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a72535dc3f4d0a3abe74213f48e31cb1
https://pubmed.ncbi.nlm.nih.gov/35302647
https://pubmed.ncbi.nlm.nih.gov/35302647
Publikováno v:
Journal of Clinical Oncology. 41:519-519
519 Background: Upper gastrointestinal bleeding associated with esophagogastric varices (EGV) is a morbid and potentially deadly complication of advanced hepatocellular carcinoma (aHCC). However, the presence of EGV among the aHCC population receivin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34c164ed5506aa44101b6f88ff42917d
https://doi.org/10.1200/jco.2023.41.4_suppl.519
https://doi.org/10.1200/jco.2023.41.4_suppl.519
Autor:
Marisa Martin, Anum Aslam, Eman Mubarak, Cate Hofley, Kayli Lala, Sandeep Arora, David C. Madoff, Elainea Smith, Dawn Owen, Ahmed Gabr, Charles Kim, Neehar Parikh, Erica Stein, Benjamin Mervak, Kimberly Shampain, Mishal Mendiratta-Lala
Publikováno v:
Hepatoma Research. 9:21
There are multiple liver-directed treatment options for hepatocellular carcinoma (HCC), which provide curative intent, help patients achieve remission, and/or provide a bridge to transplant by controlling local tumor progression and downstaging patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb105d3e490bc1eff7a7c29f32871c53
https://doi.org/10.20517/2394-5079.2022.95
https://doi.org/10.20517/2394-5079.2022.95
Autor:
William R, Masch, Rony, Kampalath, Neehar, Parikh, Kimberly A, Shampain, Anum, Aslam, Victoria, Chernyak
Publikováno v:
Abdominal radiology (New York). 46(8)
Systemic therapy for the treatment of hepatocellular carcinoma (HCC) has rapidly evolved over the last 4 years; eight new drug regimens have gained Food and Drug Administration approval for treatment of advanced HCC since 2017. As several lines of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4bc34ff870744d4e3ba6ae8d512424d8
https://pubmed.ncbi.nlm.nih.gov/33950406
https://pubmed.ncbi.nlm.nih.gov/33950406
Autor:
Jagpreet Chhatwal, Sumeyye Samur, Ju Dong Yang, Lewis R. Roberts, Mindie Nguyen, A. Burak Ozbay, Turgay Ayer, Neehar Parikh, Amit G. Singal
Publikováno v:
Journal of Clinical Oncology. 40:405-405
405 Background: Hepatocellular carcinoma (HCC) is the fastest rising cause of cancer mortality in the United States. Although clinical guidelines recommend ultrasound (U/S), with or without the serum biomarker alpha fetoprotein (AFP) for HCC surveill
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4fb019191c33d6d964e6ea8e69d58d2
https://doi.org/10.1200/jco.2022.40.4_suppl.405
https://doi.org/10.1200/jco.2022.40.4_suppl.405
Autor:
Binu John, Kyle Porter, Bassam Dahman, Neehar Parikh, Alvin C. Silva, Ju Dong Yang, Patrick Joseph, Laura E. Strong, Paul J. Limburg
Publikováno v:
Journal of Clinical Oncology. 40:TPS486-TPS486
TPS486 Background: Hepatocellular carcinoma (HCC) is a major cause of cancer-related death in the U.S. HCC surveillance is associated with improved early detection and receipt of curative treatment. However, current surveillance strategies suffer fro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43b0230f7ff39273ca46648cb5560e13
https://doi.org/10.1200/jco.2022.40.4_suppl.tps486
https://doi.org/10.1200/jco.2022.40.4_suppl.tps486